Literature DB >> 19250382

4p16.3 haplotype modifying age at onset of Huntington disease.

A Nørremølle1, E Budtz-Jørgensen, K Fenger, J E Nielsen, S A Sørensen, L Hasholt.   

Abstract

Huntington disease (HD) is caused by an expanded CAG repeat sequence in the HD gene. Although the age at onset is correlated to the CAG repeat length, this correlation only explains approximately half of the variation in onset age. Less variation between siblings indicates that the variation is, in part, explained by genetic modifiers. We analyzed polymorphic loci within or close to the HD gene on the HD chromosome in Danish HD patients. We found one specific haplotype segregating with later age at onset, compared with patients with similar CAG repeat length and another haplotype. The nine Danish families in the study carrying this haplotype most likely have a common founder. Several of the polymorphic loci displayed alleles that may be specific to the late-onset haplotype, implicating that from this study we cannot determine which of the loci tested (or other polymorphic loci in this chromosomal area) do in fact contain genetic modifiers of age at onset.

Entities:  

Mesh:

Year:  2009        PMID: 19250382     DOI: 10.1111/j.1399-0004.2008.01136.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  7 in total

1.  A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease.

Authors:  Kristina Bečanović; Anne Nørremølle; Scott J Neal; Chris Kay; Jennifer A Collins; David Arenillas; Tobias Lilja; Giulia Gaudenzi; Shiana Manoharan; Crystal N Doty; Jessalyn Beck; Nayana Lahiri; Elodie Portales-Casamar; Simon C Warby; Colúm Connolly; Rebecca A G De Souza; Sarah J Tabrizi; Ola Hermanson; Douglas R Langbehn; Michael R Hayden; Wyeth W Wasserman; Blair R Leavitt
Journal:  Nat Neurosci       Date:  2015-05-04       Impact factor: 24.884

2.  Response to Falush: a role for cis-element polymorphisms in HD.

Authors:  Simon C Warby; Henk Visscher; Stefanie Butland; Christopher E Pearson; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

Review 3.  Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.

Authors:  Hongfei Jiang; Hang Hu; Xiaomei Tong; Qiuhong Jiang; Haiyan Zhu; Songying Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-24       Impact factor: 4.553

4.  Haplotype analysis of the 4p16.3 region in Portuguese families with Huntington's disease.

Authors:  Eliana Marisa Ramos; Tammy Gillis; Jayalakshmi S Mysore; Jong-Min Lee; Martin Gögele; Yuri D'Elia; Irene Pichler; Jorge Sequeiros; Peter P Pramstaller; James F Gusella; Marcy E MacDonald; Isabel Alonso
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-02-05       Impact factor: 3.568

5.  CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.

Authors: 
Journal:  Cell       Date:  2019-08-08       Impact factor: 41.582

6.  A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.

Authors:  Marc Ciosi; Alastair Maxwell; Sarah A Cumming; Davina J Hensman Moss; Asma M Alshammari; Michael D Flower; Alexandra Durr; Blair R Leavitt; Raymund A C Roos; Peter Holmans; Lesley Jones; Douglas R Langbehn; Seung Kwak; Sarah J Tabrizi; Darren G Monckton
Journal:  EBioMedicine       Date:  2019-10-10       Impact factor: 8.143

7.  Di-ethylhexylphthalate (DEHP) modulates cell invasion, migration and anchorage independent growth through targeting S100P in LN-229 glioblastoma cells.

Authors:  Jennifer Nicole Sims; Barbara Graham; Maricica Pacurari; Sophia S Leggett; Paul B Tchounwou; Kenneth Ndebele
Journal:  Int J Environ Res Public Health       Date:  2014-05-09       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.